Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers

Journal of Research in Medical Sciences

Volumn 19, Issue SPEC. ISSUE, 2014, Pages

  Javadi, Abbasali ^a   Ataei, Behrooz ^a   Kassaian, Nazila ^b   Nokhodian, Zary ^b   Yaran, Majid ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Co infection; Drop in center; Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; RISK FACTOR; SOCIAL WORKER;

EID: 84900343359     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Curry MP, Chopra S, Dienstag JL. Viral hepatitis. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 7th ed. New York: Churchill-Livingstone; 2010. p. 1577-93.
2. UNAIDS. UNAIDS Report on the Global AIDS Epidemic 2010, 2010. Available from: http://www.unaids.org/globalreport/ documents/20101123_GlobalReport_full_en.pdf. [Last accessed on 2013 Mar 28]
3. National AIDS Committee, Ministry of Health. Iran Country Report on Monitoring of the United Nations General Assembly Special Session on HIV and AIDS, Declaration of Commitment [in Persian]. Tehran: Iranian Ministry of Health; 2008. p. 19-21.
4. Alavian SM, Adibi P, Zali MA. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iran Med 2005;8:84-90.
5. Forouzanfar MH, Mohammad K, Majdzadeh R, Malekzadeh R, Abolhasani F, Ohammadnejad M, et al. Eff ectiveness of adolescent immunization against hepatitis B on burden of the disease in Iran. Hakim Res J 2006;9:1-11.
6. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, et al. Seroprevalence of hepatitis C virus: The first population-based study from Iran. Int J Infect Dis 2010;14 Suppl 3:e113-6.
7. Arababadi MK, Hassanshahi G, YousefiH. HBV-DNA in hemodialysis patients infected by HCV. Saudi J Kidney Dis Transpl 2009;20:398-401.
8. Razzaghi EM, Movaghar AR, Green TC, Khoshnood K. Profiles of risk: A qualitative study of injecting drug users in Tehran, Iran. Harm Reduct J 2006;3:12.
9. Vahdani P, Hosseini-Moghaddam SM, Family A, Moheb-Dezfouli R. Prevalence of HBV, HCV, HIV and syphilis among homeless subjects older than fifteen years in Tehran. Arch Iran Med 2009;12:483-7.
10. Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry JV. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: Results of a national cross sectional survey. BMJ 2000;321:78-82.
11. Rowhani-Rahbar A, Tabatabaee-Yazdi A, Panahi M. Prevalence of common blood-borne infections among imprisoned injection drug users in Mashhad, North-East of Iran. Arch Iran Med 2004;7:190-4.
12. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. Lancet 2008;372:1733-45.
13. Rahimi-Movaghar A, Amin-Esmaeili M, Haghdoost AA, Sadeghirad B, Mohraz M. HIV prevalence amongst injecting drug users in Iran: A systematic review of studies conducted during the decade 1998-2007. Int J Drug Policy 2012;23:271-8.
14. Leeratanapetch N, Suseangrut W. Hepatitis B virus and hepatitis C virus co-infection with HIV patients at Khon Kaen Hospital. Khon Kaen Hosp Med J 2008;32:229-38.
15. Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin- Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus coinfections among injecting drug users in Tehran, Iran. Int J Infect Dis 2010;14:e28-33.
16. SeyedAlinaghi S, Jam S, Mehrkhani F, Fattahi F, Sabzvari D, Kourorian Z, et al. Hepatitis-C and hepatitis-B co-infections in patients with human immunodeficiency virus in Tehran, Iran. Acta Med Iran 2011;49:252-7.
17. Devikh S, Singh NB, Singh HL, Singh YM. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users. J Indian Med Assoc 2009;107:144, 146-7.
18. Razaghi EM, Rahimi-Movaghar A, Amin-Esmaeili M, Sahimi Izadian E, Bagh-Estani AR. The study of prevalence of infectious diseases among injecting drug abusers and their correlated factors in Tehran in 2006-2007. Tehran: Iranian National Center for Addiction Studies; 2008.
19. Malekinejad M, Vazirian M. Transition to injection amongst opioid users in Iran: Implications for harm reduction. Int J Drug Policy 2012;23:333-7.
20. Fauci AS, Lane HC. Human immunodeficiency virus disease: AIDS and related disorders. In: Longo D, Fauci AS, Kasper D, Hauler SL, Longo DL, Jameson JL, editors. Harrison's Principles of Internal Medicine. 18th ed. New York: McGraw Hill; 2012. p. 3506-87.
21. Dienstag JL. Chronic hepatitis. In: Longo D, Fauci AS, Kasper D, Hauler SL, Longo DL, Jameson JL, editors. Harrison's Principles of Internal Medicine. 18th ed. New York: McGraw Hill; 2012. p. 2567-88.
22. Di Martino V, Thevenot T, Colin JF, Boyer N, Martinot M, Degos F, et al. Infl uence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology 2002;123:1812-22.
23. Puoti M, Torti C, Bruno R, Filice G, Carosi G. Natural history of chronic hepatitis B in co-infected patients. J Hepatol 2006;44:S65-70.
24. Ranjbar R, Davari A, Izadi M, Jonaidi N, Alavian SM. HIV/HBV co-infections: Epidemiology, natural history, and treatment: A review article. Iran Red Crescent Med J 2011;13:855-62.
25. Schnuriger A, Dominguez S, Guiguet M, Harfouch S, Samri A, Ouazene Z, et al. Acute hepatitis C in HIV-infected patients: Rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus. AIDS 2009;23:2079-89.
26. Soriano V, Puoti M, Peters M, Benhamou Y, Sulkowski M, Zoulim F, et al. Care of HIV patients with chronic hepatitis B: Updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS 2008;22:1399-410.
27. Rezaianzadeh A, Hasanzadeh J, Alipour A, Davarpanah MA, Rajaeifard A, Tabatabaee SH. Impact of hepatitis C on survival of HIV-infected individuals in Shiraz; South of Iran. Hepat Mon 2012;12:106-11.
28. Mir-Nasseri MM, Mohammadkhani A, Tavakkoli H, Ansari E, Poustchi H. Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users. Hepat Mon 2011;11:19-22.
29. Radfar R, Nematollahi P, Tayeri K. Study on prevalence of HIV, HCV and HBV among IDU clients in IRANDOOST residential center, Isfahan. In: Paper Presented at the First National Congress of Infection in Addicts Isfahan, Iran; 2007.
30. Semnani S, Roshandel G, Abdolahi N, Besharat S, Keshtkar AA, Joshaqani HR, et al. HBV/HCV co-infection in Iran: A seroepidemiological based study. Pak J Biol Sci 2006;9:2538-40.
31. Chu CJ, Lee SD. Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment. J Gastroenterol Hepatol 2008;23:512-20.
32. Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ. HIV and hepatitis C coinfection within the CAESAR study. HIV Med 2004;5:174-9.
33. Hagan H, Thiede H, Des Jarlais DC. HIV/hepatitis C virus coinfection in drug users: Risk behavior and prevention. AIDS 2005;19 Suppl 3:S199-207.
34. Azarkar Z, Sharifzadeh G. Evaluation of the prevalence of Hepatitis B, Hepatitis C, and HIV in inmates with drug-related convictions in Birjand, Iran in 2008. Hepat Mon 2010;10:26-30.
35. Buxton JA, Yu A, Kim PH, Spinelli JJ, Kuo M, Alvarez M, et al. HCV co-infection in HIV positive population in British Columbia, Canada. BMC Public Health 2010;10:225.
36. Nokhodian Z, Ataei B, Kassaian N, Yaran M, Hassannejad R, Adibi P. Seroprevalence and risk factors of Hepatitis C virus among juveniles in correctional center in Isfahan, Iran. Int J Prev Med 2012;3 Suppl 1:S113-7.
37. Hoff mann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 2007;7:402-9.
38. Brown AE, Ross DA, Simpson AJ, Erskine RS, Murphy G, Parry JV, et al. Prevalence of markers for HIV, hepatitis B and hepatitis C infection in UK military recruits. Epidemiol Infect 2011;139:1166-71.
39. Saleh-Gargari S, Hantoushzadeh S, Zendehdel N, Jamal A, Aghdam H. The association of maternal HBsAg carrier status and perinatal outcome. Hepat Mon 2009;9:180-4.
40. Hajiani E, Hashemi S, Masjedizadeh A. Seroepidemiology of hepatitis B virus infection in Khuzestan province, Southwest of Iran. Hepat Mon 2009;9:34-8.